We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
GP Nutrition is a nutrition company that creates products meant to deliver sustainable weight loss. This award-winning company was created by Gabriela Peacock, a celebrity nutritionist. It has 13,000 global customers who have bought more than 30,000 packs. In June'19, the company reached trading of £50k per month. It has produced 22 products that are now sold in 30 countries. GP Nutrition has delivered revenue of £377k and an EBITDA of £813,389. Nutrition's vision is to solve the 95% failure rate of diets in the USA and the UK.
days to go: Expired investment: £309,890
Creating all-natural meals using real ingredients and delivering them directly to a customer's door. Detox Kitchen runs two delis located in central London and since launching, they have delivered more than 1 million meals. On average, the company serves over 2,500 customers per week from both of its delis. This has resulted in average sales of £243k per month and a YoY growth of 70%. Funds will be allocated towards increasing the capacity of their kitchen to meet customer demand and improve their online technology platform from which customers place their orders. In addition, Detox Kitchen seek to market and advertise their services by hiring marketing professionals to attract more customers to the business.
days to go: Expired investment: £581,740
A crisps company with the mission of making tasty and healthy snacks. Emily Crisps are vegan, gluten-free, halal and kosher certified, as well as being 1 of a 5 per day. Their products are sold in major grocery stores such as Sainsbury's and Tesco, which are responsible for 50% of the company's revenue. Emily Crisps are well-established in the UK and are now seeking funds to expand to the US, with a dedicated marketing campaign and sales team.
days to go: Expired investment: £1,048,030
Similar to the functionality of workplace pensions, employees can invest part of their pay into an ISA and start to build a healthy saving habit. Smarterly's current clients include Rolls Royce, Samsung and OVO Energy and they have identified 85 other organisations with a collective 600,000 employees as potential opportunities. Due to the fundamentals of Smarterly being automated, there is no need to pay for a large staff and revenue is generated via small fees.
days to go: Expired investment: £1,638,150
Baanx is a Business to Business to Consumer (B2B2C) banking platform that is Application Programming Interface (API) driven and digital-friendly. It aims to become a contender in the digital asset financial services market that is expected to rise and expand to over 580 million people or 7+% of the world population by 2022. Baanx argues that it is disrupting the slow and expensive banking sector by leveraging blockchain to launch secure and low-cost banking products and services, with a few lines of code. Baanx offers its users 'Digital wallets' (via API or a custom mobile app), crypto-friendly debit cards in physical and virtual formats, and allows users to send fiat or cryptocurrencies to anyone in their contact list with 'zero' Foreign Exchange (FX) fees, through its proprietary software, TextBit.  
days to go: Expired investment: £9,500,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph